Drug repurposing from the perspective of pharmaceutical companies

E-ISSN： 1476-5381|175|2|168-180

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.2, 2018-01, pp. : 168-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 247-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of unethical conduct of pharmaceutical companies on consumer behavior: Empirical evidence from Germany

By Lindenmeier Jörg Tscheulin Dieter K. Drevs Florian

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 6, Iss. 2, 2012-06 ,pp. : 108-123

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Drug repurposing screens and synergistic drug‐combinations for infectious diseases

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 181-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug repurposing to treat asthma and allergic disorders: Progress and prospects

ALLERGY, Vol. 73, Iss. 2, 2018-02 ,pp. : 313-322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inventing new therapies without reinventing the wheel: the power of drug repurposing

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 165-167

John Wiley & Sons Inc

Access to resources Recommend Favorite